IMPORTANT INFORMATION

The information contained in this section of Spago Nanomedical AB (publ)’s (the "Company") website is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States of America (including its territories and possessions, any state of the United States and the District of Columbia, the "United States"), Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Singapore, Switzerland, Russia or Belarus or any other jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction, and does not constitute an offer to sell, or a solicitation of an offer to purchase, any shares or other securities of the Company in any jurisdiction where to do so might be unlawful, constitute a violation of the local securities laws or regulations of such jurisdiction or would require any registration or licensing within such jurisdiction.

No subscription rights, paid subscription shares (Sw. betalda tecknade aktier) or new shares in the Company ("Securities") may be offered, subscribed, sold or distributed, directly or indirectly, in or to, the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Singapore, Switzerland, Russia or Belarus or any other jurisdiction where it would be unlawful or participation would require additional prospectuses, registrations or other measures than pursuant to Swedish law.

No public offering of Securities is made to any country within the European Economic Area (the "EEA") other than Sweden. No Securities has been, or will be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or the securities legislation of any state or other jurisdiction of the United States.

Access to the information and documents contained on the following website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons residing outside of Sweden who wish to have access to the information and documents contained on this website should firstly ensure that they are not subject to any sanctions, local laws or regulations that prohibit or restrict their right to access this section of the website or require registration or approval of any acquisition of Securities by them. No such registration or approval has been obtained outside Sweden. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.